We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2492:TWSEWalsin Technology Corporation Analysis

Data as of 2026-05-23 - not real-time

NT$292.50

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Walsin Technology (2492.TW) is trading at TWD 292.5, which sits at its 52‑week high and sits well above the 20‑day (TWD 182.1), 50‑day (TWD 151.8) and 200‑day (TWD 121.6) simple moving averages, confirming a strong bullish trend. The MACD is bullish (line above signal, positive histogram) and volume is increasing, but the RSI of 85.4 places the stock in overbought territory, suggesting a near‑term pull‑back risk. Volatility is elevated at 86.7% over the past 30 days, while beta is modest (≈0.88), indicating the price swings are more company‑specific than market‑driven.
Fundamentally, the stock appears stretched: a trailing P/E of 61.7 far exceeds the industry average of 39.5, and the DCF‑derived fair value of TWD 112.8 is less than half the current price. However, forward earnings are projected to jump (forward EPS 17.38 vs trailing 4.74) giving a forward P/E of 16.8, which tempers the valuation gap. The balance sheet is leveraged, with debt ≈ TWD 29.3 B against cash ≈ TWD 14.3 B (debt‑to‑equity ≈ 45.5), and ROE is modest at 5.2%. The dividend yield is low (0.82%) and the payout ratio of 51% raises questions about long‑term sustainability.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI in overbought zone
  • Price at 52‑week high
  • Bullish MACD but potential short‑term correction

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong forward earnings growth (forward P/E 16.8)
  • Increasing trading volume
  • Diversified exposure to high‑growth end‑markets (IoT, green energy)

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High valuation gap vs DCF
  • Elevated debt levels
  • Sustainable product portfolio across multiple tech segments

Key Metrics & Analysis

Financial Health

Revenue Growth9.10%
Profit Margin6.80%
P/E Ratio61.7
ROE5.21%
ROA1.42%
Debt/Equity45.46
P/B Ratio4.5
Op. Cash FlowNT$5.5B
Free Cash FlowNT$3.6B
Industry P/E39.5

Technical Analysis

TrendBullish
RSI85.4
SupportNT$124.00
ResistanceNT$292.50
MA 20NT$182.08
MA 50NT$151.84
MA 200NT$121.56
MACDBullish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

Fair ValueNT$112.76
GradeOvervalued
TypeBlend
Dividend Yield0.82%

Risk Assessment

Beta0.88
Volatility86.74%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.